Martingale Asset Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-6,603
Closed -$225K 894
2022
Q4
$225K Sell
6,603
-750
-10% -$25.1K ﹤0.01% 769
2022
Q3
$224K Sell
7,353
-8,303
-53% -$285K ﹤0.01% 764
2022
Q2
$584K Hold
15,656
0.01% 615
2022
Q1
$711K Buy
15,656
+100
+0.6% +$4.38K 0.01% 566
2021
Q4
$750K Sell
15,556
-201
-1% -$10.1K 0.01% 557
2021
Q3
$877K Buy
15,757
+9,150
+138% +$508K 0.01% 539
2021
Q2
$359K Sell
6,607
-100
-1% -$5.49K ﹤0.01% 683
2021
Q1
$377K Buy
6,707
+697
+12% +$34.8K ﹤0.01% 690
2020
Q4
$262K Sell
6,010
-28,900
-83% -$1.14M ﹤0.01% 770
2020
Q3
$1.36M Buy
34,910
+19,607
+128% +$861K 0.02% 542
2020
Q2
$662K Buy
+15,303
New +$579K 0.01% 821
2015
Q2
Sell
-8,405
Closed -$219K 906
2015
Q1
$219K Buy
+8,405
New +$200K 0.01% 831
2013
Q3
Sell
-12,705
Closed -$255K 1043
2013
Q2
$255K Buy
+12,705
New +$318K 0.01% 890

Other funds holding SRDX

Martingale Asset Management's SRDX Position: Q1 2023 in Review

Martingale Asset Management sold out of Surmodics (SRDX) in Q1 2023, closing a stake of 6,603 shares — an estimated $225K sold.

Martingale Asset Management first reported a position in SRDX in Q2 2013 and held it in 13 quarters. The position peaked at $1.36M in Q3 2020. 119 funds tracked by Wall St. Rank hold SRDX as of Q1 2023.

  • Martingale Asset Management reported no remaining Surmodics position as of Q1 2023 after selling out during the quarter.
  • Martingale Asset Management sold 6,603 Surmodics shares in Q1 2023, an estimated $225K.
  • Martingale Asset Management first reported a position in Surmodics in Q2 2013 and held it in 13 quarters.
  • Martingale Asset Management's Surmodics position peaked at $1.36M in Q3 2020.
  • 119 funds tracked by Wall St. Rank held Surmodics as of Q1 2023.

Based on Martingale Asset Management's 13F filing for Q1 2023, filed 12 May 2023.